2Edaravone Acute Infarction Study Group.Effectof a novel free radical scavenger,edaravone(MCI-186),on acute brain infarction.Randomized,placebo-controlled,doubl-blind study at multicenters[J].Cerebrovasclar Diseases,2003,15:222-229.
3Tanaka M.Pharmacological and clinical profile of the free radical scavenger edaravone as a neueoprotective agent[J].Nippon Yakurigaku Zasshi,2002,119:301.
4Watanabe T,Yuki S,Egawa M,et al.Protective effects of MCl -186on cerebral ischemia:possible involvement of free radical scavenging and antioxidant actions[J].J Pharmacol Exp Ther,1994,268:1597-1604.
5Tanaka M.Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent[J].Nippon Yakurigaku Zasshi,2002,119:301-308.
6Ikeda T,Xia YX,Kaneko M,et al.Effect of the free radical scavenger,3-methy-1-phenyl-2-pyrazolin-5-one (MCI-186),on hypoxia -ischemia -induced brain iniury in neonatal rats[J].Neurosci Lett,2002,329:33-36.
8Edaravone Acute Infarction Study Group.Effect of a novel free radical scavenger,edaravone (MCI-186),on acute brain infarction.Randomized,placebo-controlled,double-blind study at multicenters[J].Cerebrovasc Dis,2003,15:222-229.
9Takabatake Y,Uno E,Wakamatsu K,et al.The clinical effect of combination therapy with edaravone and sodium ozagrel for acute cerebral infarction[J].No ToShinkei,2003,55:589-593.
10Rother E, Brandl R, Baber DL, et al. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques [ J ]. Circulation ,2003,108 ( 6 ) :741
